CH641152A5 - Process for preparing thymosin alpha-1 and an analogue - Google Patents

Process for preparing thymosin alpha-1 and an analogue Download PDF

Info

Publication number
CH641152A5
CH641152A5 CH408878A CH408878A CH641152A5 CH 641152 A5 CH641152 A5 CH 641152A5 CH 408878 A CH408878 A CH 408878A CH 408878 A CH408878 A CH 408878A CH 641152 A5 CH641152 A5 CH 641152A5
Authority
CH
Switzerland
Prior art keywords
obzl
glu
bzl
lys
ala
Prior art date
Application number
CH408878A
Other languages
German (de)
English (en)
Inventor
Su-Sun Wang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/871,563 external-priority patent/US4116951A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH641152A5 publication Critical patent/CH641152A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH408878A 1977-04-22 1978-04-17 Process for preparing thymosin alpha-1 and an analogue CH641152A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78989877A 1977-04-22 1977-04-22
US05/871,563 US4116951A (en) 1977-04-22 1978-01-23 [Asn2 ]-thymosin α1 and analogs thereof

Publications (1)

Publication Number Publication Date
CH641152A5 true CH641152A5 (en) 1984-02-15

Family

ID=27120967

Family Applications (3)

Application Number Title Priority Date Filing Date
CH408878A CH641152A5 (en) 1977-04-22 1978-04-17 Process for preparing thymosin alpha-1 and an analogue
CH644982A CH640218A5 (en) 1977-04-22 1982-11-05 Peptide derivatives
CH645082A CH641153A5 (en) 1977-04-22 1982-11-05 Thymosin alpha-1 fragments and their preparation

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH644982A CH640218A5 (en) 1977-04-22 1982-11-05 Peptide derivatives
CH645082A CH641153A5 (en) 1977-04-22 1982-11-05 Thymosin alpha-1 fragments and their preparation

Country Status (18)

Country Link
JP (1) JPS53137914A (it)
AT (1) AT364470B (it)
CA (1) CA1113088A (it)
CH (3) CH641152A5 (it)
DE (1) DE2817082A1 (it)
DK (1) DK147918C (it)
ES (1) ES469016A1 (it)
FI (1) FI781241A (it)
FR (2) FR2401134A1 (it)
GB (1) GB1590668A (it)
GR (1) GR71886B (it)
HU (1) HU180783B (it)
IT (1) IT1113134B (it)
LU (1) LU79488A1 (it)
NL (1) NL7804364A (it)
NO (2) NO781404L (it)
PT (1) PT67937B (it)
SE (1) SE447262B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1

Also Published As

Publication number Publication date
IT7822629A0 (it) 1978-04-21
NL7804364A (nl) 1978-10-24
SE447262B (sv) 1986-11-03
FR2405926A1 (fr) 1979-05-11
FR2401134A1 (fr) 1979-03-23
PT67937B (en) 1980-04-07
FR2405926B1 (it) 1983-09-09
NO821608L (no) 1978-10-24
ES469016A1 (es) 1980-01-01
GB1590668A (en) 1981-06-03
NO148924C (no) 1984-01-11
DK169478A (da) 1978-10-23
ATA286178A (de) 1981-03-15
CA1113088A (en) 1981-11-24
DE2817082A1 (de) 1978-11-02
JPS53137914A (en) 1978-12-01
IT1113134B (it) 1986-01-20
FI781241A (fi) 1978-10-23
PT67937A (en) 1978-05-01
GR71886B (it) 1983-08-04
FR2401134B1 (it) 1983-09-30
CH640218A5 (en) 1983-12-30
AT364470B (de) 1981-10-27
NO148924B (no) 1983-10-03
NO781404L (no) 1978-10-24
CH641153A5 (en) 1984-02-15
HU180783B (en) 1983-04-29
SE7804612L (sv) 1978-12-20
DK147918B (da) 1985-01-07
DK147918C (da) 1985-08-19
LU79488A1 (de) 1979-05-25

Similar Documents

Publication Publication Date Title
DE3428942C2 (de) (h-pth)-peptidderivate
US4148788A (en) Synthesis of thymosin α1
DE69117788T2 (de) Parathyroid-Hormon-Antagonisten
US4116951A (en) [Asn2 ]-thymosin α1 and analogs thereof
DE2616399C2 (de) Desamino-1,7-dicarbacalcitonine und Verfahren zu ihrer Herstellung
EP0147193B1 (en) Peptide production and use thereof
EP0001295B1 (de) Somatostatin-analoge Cyclopeptide, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Anwendung
DE3782010T2 (de) Vom calcitonin-gen abgeleitete peptidderivate.
BG61125B2 (bg) Циклични вазоактивни пептидни аналози
DE68905552T2 (de) Immunostimulierende peptide, deren verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
CH641152A5 (en) Process for preparing thymosin alpha-1 and an analogue
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
DE3881467T2 (de) Vasokonstriktor-Peptid.
WO1989010935A1 (en) Atrial peptide derivatives
US3873511A (en) (1-{60 -Aminoisobutyric acid)-corticotropin peptides
US5091366A (en) Peptides having ANF activity
DE3586940T2 (de) Polypeptid und dessen Verfahren zur Herstellung.
DE2732451A1 (de) Peptidverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0431113A1 (en) Atrial peptide derivatives
US4018754A (en) Novel polypeptides having ACTH-like action
US3873510A (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof
EP0003028A1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
CH422813A (de) Verfahren zur Herstellung neuer Polypeptide
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
US4238390A (en) Synthesis and biological activity of [D-Thr2, Δ3 Pro5 ]-enkephalinamide

Legal Events

Date Code Title Description
PL Patent ceased